FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2031142384> ?p ?o ?g. }

• W2031142384 abstract "It is known that in the presence of even subtle kidney dysfunction an intensive prevention of cardiovascular risk is required. Apart from the conventional factors which contribute to cardiovascular disease (CVD), there are also some specific conditions of the chronic kidney disease (CKD) population such as oxidative stress of uremia and dialysis (D). However, hyperphosphatemia, hypercalcemia, and elevated calcium-phosphorus product remain as major contributors to the development of vascular calcification (VC) in this population, as part of the systemic complication known as mineral and bone disorders (MBD) in CKD patients. Importantly, the retention of phosphate remains as main culprit in the pathogenesis of CKD–-MBD. Over the years, various treatment options for phosphate removal and controlling mineral metabolism, bone health, VC and CVD have failed, mainly through an over-suppression of PTH, development of ABD and promotion of VC and mortality. Although KDOQI and KDIGO published CKD–-MBD guidelines has clearly stated where calcium-based phosphate binders should not be used in D patients (hypercalcemia and low PTH) and where non calcium-containing phosphate binders are preferred (patients with severe vascular and/or other soft tissue calcifications), the greatest controversy and disagreements within the nephrological community still exists upon the cost-effectiveness of non calcium binder (sevelamer) use. Indeed, despite the evidence and recognised trend towards both a decrease in VC and CVD associated with sevelamer use, it is still an ongoing matter of debate. The magnitude of this controversy is increased when the issue of advanced medical and/or budgetary evaluation related to the implementation of clinical guidelines for CKD–-MBD treatment is considered. Despite advocated use of sevelamer across a range of common clinical scenarios in CKD, its widespread utilization is challenged as exceeding what would usually be considered good value for money. If so, it is questionable whether the recommendations and suggestions from the guidelines should be followed, and further, do we need guidelines and innovative drugs for treatment of hyperphosphatemia? While awaiting the answer, as clinicians we should proceed with a treatment to “do no harm”, trying to at least limit the calcium exposure of our dialysis patients." @default.
• W2031142384 created "2016-06-24" @default.
• W2031142384 creator A5040098583 @default.
• W2031142384 date "2011-01-01" @default.
• W2031142384 modified "2023-09-25" @default.
• W2031142384 title "A Review of Sevelamer Hydrochloride in End-Stage Renal Disease Patients on Dialysis" @default.
• W2031142384 cites W1977645780 @default.
• W2031142384 cites W1978513267 @default.
• W2031142384 cites W1992723875 @default.
• W2031142384 cites W2011005615 @default.
• W2031142384 cites W2013826249 @default.
• W2031142384 cites W2017940864 @default.
• W2031142384 cites W2023653442 @default.
• W2031142384 cites W2034333557 @default.
• W2031142384 cites W2037687164 @default.
• W2031142384 cites W2038550793 @default.
• W2031142384 cites W2043261965 @default.
• W2031142384 cites W2045847718 @default.
• W2031142384 cites W2055388173 @default.
• W2031142384 cites W2064232755 @default.
• W2031142384 cites W2069942555 @default.
• W2031142384 cites W2071433603 @default.
• W2031142384 cites W2073967243 @default.
• W2031142384 cites W2082301185 @default.
• W2031142384 cites W2105024958 @default.
• W2031142384 cites W2106575967 @default.
• W2031142384 cites W2107207648 @default.
• W2031142384 cites W2112045675 @default.
• W2031142384 cites W2114164409 @default.
• W2031142384 cites W2114724047 @default.
• W2031142384 cites W2122136837 @default.
• W2031142384 cites W2124526413 @default.
• W2031142384 cites W2136128927 @default.
• W2031142384 cites W2138247546 @default.
• W2031142384 cites W2139219622 @default.
• W2031142384 cites W2142627457 @default.
• W2031142384 cites W2164209348 @default.
• W2031142384 cites W2167092665 @default.
• W2031142384 cites W2172159264 @default.
• W2031142384 cites W2328615536 @default.
• W2031142384 cites W2409952302 @default.
• W2031142384 cites W2900987534 @default.
• W2031142384 cites W3010153256 @default.
• W2031142384 cites W3144430126 @default.
• W2031142384 cites W94346301 @default.
• W2031142384 doi "https://doi.org/10.4137/cmt.s5990" @default.
• W2031142384 hasPublicationYear "2011" @default.
• W2031142384 type Work @default.
• W2031142384 sameAs 2031142384 @default.
• W2031142384 citedByCount "1" @default.
• W2031142384 crossrefType "journal-article" @default.
• W2031142384 hasAuthorship W2031142384A5040098583 @default.
• W2031142384 hasBestOaLocation W20311423841 @default.
• W2031142384 hasConcept C126322002 @default.
• W2031142384 hasConcept C134018914 @default.
• W2031142384 hasConcept C177713679 @default.
• W2031142384 hasConcept C2776036575 @default.
• W2031142384 hasConcept C2776635150 @default.
• W2031142384 hasConcept C2777425297 @default.
• W2031142384 hasConcept C2778063415 @default.
• W2031142384 hasConcept C2778653478 @default.
• W2031142384 hasConcept C2779148903 @default.
• W2031142384 hasConcept C2779978075 @default.
• W2031142384 hasConcept C2908647359 @default.
• W2031142384 hasConcept C71924100 @default.
• W2031142384 hasConcept C99454951 @default.
• W2031142384 hasConceptScore W2031142384C126322002 @default.
• W2031142384 hasConceptScore W2031142384C134018914 @default.
• W2031142384 hasConceptScore W2031142384C177713679 @default.
• W2031142384 hasConceptScore W2031142384C2776036575 @default.
• W2031142384 hasConceptScore W2031142384C2776635150 @default.
• W2031142384 hasConceptScore W2031142384C2777425297 @default.
• W2031142384 hasConceptScore W2031142384C2778063415 @default.
• W2031142384 hasConceptScore W2031142384C2778653478 @default.
• W2031142384 hasConceptScore W2031142384C2779148903 @default.
• W2031142384 hasConceptScore W2031142384C2779978075 @default.
• W2031142384 hasConceptScore W2031142384C2908647359 @default.
• W2031142384 hasConceptScore W2031142384C71924100 @default.
• W2031142384 hasConceptScore W2031142384C99454951 @default.
• W2031142384 hasLocation W20311423841 @default.
• W2031142384 hasOpenAccess W2031142384 @default.
• W2031142384 hasPrimaryLocation W20311423841 @default.
• W2031142384 hasRelatedWork W1249976828 @default.
• W2031142384 hasRelatedWork W1967794921 @default.
• W2031142384 hasRelatedWork W1973075629 @default.
• W2031142384 hasRelatedWork W1974770715 @default.
• W2031142384 hasRelatedWork W1988019172 @default.
• W2031142384 hasRelatedWork W1996457987 @default.
• W2031142384 hasRelatedWork W2075015922 @default.
• W2031142384 hasRelatedWork W2105044947 @default.
• W2031142384 hasRelatedWork W2106608685 @default.
• W2031142384 hasRelatedWork W2112667454 @default.
• W2031142384 hasRelatedWork W2113262086 @default.
• W2031142384 hasRelatedWork W2115435669 @default.
• W2031142384 hasRelatedWork W2118920747 @default.
• W2031142384 hasRelatedWork W2139106859 @default.
• W2031142384 hasRelatedWork W2139932170 @default.
• W2031142384 hasRelatedWork W2165906757 @default.
• W2031142384 hasRelatedWork W2326474342 @default.
• W2031142384 hasRelatedWork W2345701662 @default.

• next